Company intelligence / Profile preview

Opharmic Technology

Shatin, New Territories, Hong Kong

Ownership: Private
Development stage: Other

Overview

Opharmic is developing a non-invasive ultrasound device to deliver drugs to the eye, reducing the need for intraocular injections; the core product has reached pre-clinical proof-of-concept with ongoing development

Therapeutic areas: Ophthalmology
Modalities: DeviceUltrasound-based drug delivery
Industry: Therapeutic Medical Devices

Partnerships

Turnkey solutions for pharmaceutical partners on drug delivery platforms; no major pharma partnerships named in search results

Beyond the preview

Go deeper on Opharmic Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Opharmic Technology.

Explore the full profile